Zeo ScientifiX (ZEOX) Other financing activities (2015)
Zeo ScientifiX (ZEOX) posted quarterly Other financing activities of -$6612.0 for Q4 2015, down 310.43% quarter-over-quarter from -$1611.0 in Q2 2015.
Zeo ScientifiX (ZEOX) Other financing activities (2015) Analysis & Trends
Zeo ScientifiX's Other financing activities history runs 1 years deep, the most recent figure standing at -$6612.0 for Q4 2015.
- In Q4 2015, Other financing activities changed N/A year-over-year to -$6612.0; the TTM figure through Oct 2025 stood at -$8223.0 (changed N/A YoY), while the FY2025 annual figure was $50000.0, changed N/A from the prior year.
- Other financing activities for Q4 2015 stood at -$6612.0, down from -$1611.0 in the prior quarter.
- The five-year high for Other financing activities was $3469.0 in Q1 2015, with the low at -$6612.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2015 | -6,612.00 |
| Oct 31, 2015 | -6,612.00 |
| Apr 30, 2015 | -1,611.00 |
| Apr 30, 2015 | -1,611.00 |
| Jan 31, 2015 | 3,469.00 |
| Jan 31, 2015 | 3,469.00 |